Clinical Trials Directory

Trials / Unknown

UnknownNCT02384148

Study of Circadian Clock Properties in Healthy Subjects, Obese and Type 2 Diabetic Patients.

Measure and Comparison of Molecular Circadian Clock Properties in Healthy Subjects, Obese and Type 2 Diabetic Patients.

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

The investigators aimed to characterize human circadian clockwork in healthy individuals in comparison to obese and type 2 diabetic subjects, employing the noninvasive experimental approach allowing the study of circadian profile in human individuals.

Detailed description

The investigators specifically aim to obtain and analyze the circadian profile of skin fibroblasts from healthy, obese and T2D subjects. Does circadian oscillator profile and its parameters (phase, period and amplitude) will differ between healthy individuals and obese/ T2D patients? Skin biopsy will be performed in order to collect and culture skin fibroblast cells. In vivo bioluminescence recording will be performed in primary human skin fibroblast cells. The profiles obtained from 10 subjects in each group will be compared to their healthy counterparts. Bmal1and Per2 are clock genes. Lentiviral transduction of Bmal1-luciferase or Per2-luciferase in fibroblasts allow observation of circadian oscillations using bioluminescence assay. Phase, period length and amplitude are used to characterize the circadian rhythm.

Conditions

Interventions

TypeNameDescription
OTHERCircadian rhythm measurement
PROCEDURESkin biopsyA 2mm diameter skin biopsy is performed by a physician using standard procedure.

Timeline

Start date
2011-06-01
Primary completion
2017-12-01
First posted
2015-03-10
Last updated
2015-12-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02384148. Inclusion in this directory is not an endorsement.